These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37673214)

  • 21. Delafloxacin
    Pfaller MA; Flamm RK; McCurdy SP; Pillar CM; Shortridge D; Jones RN
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Smayevsky J; Relloso MS; Sucari A; Pennini M; Brilla E; Vilches V; De la Cruz Y; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i43-i59. PubMed ID: 32337593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.
    Sjölund-Karlsson M; Howie RL; Crump JA; Whichard JM
    J Clin Microbiol; 2014 Mar; 52(3):877-84. PubMed ID: 24391204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.
    Wildermuth BE; Griffin CE; Rosenkrantz WS; Boord MJ
    J Am Anim Hosp Assoc; 2007; 43(6):337-41. PubMed ID: 17975216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of antimicrobial susceptibility of bacterial pathogens isolated from dogs and cats with respiratory tract infections in Europe: ComPath results.
    Moyaert H; de Jong A; Simjee S; Rose M; Youala M; El Garch F; Vila T; Klein U; Rzewuska M; Morrissey I
    J Appl Microbiol; 2019 Jul; 127(1):29-46. PubMed ID: 30955231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    Torumkuney D; Papaparaskevas J; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v36-v42. PubMed ID: 29659884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.
    Tamma PD; Harris PNA; Mathers AJ; Wenzler E; Humphries RM
    Clin Infect Dis; 2023 Nov; 77(11):1585-1590. PubMed ID: 36001445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of canine-specific minocycline and doxycycline susceptibility breakpoints for meticillin-resistant Staphylococcus pseudintermedius isolates from dogs.
    Hnot ML; Cole LK; Lorch G; Papich MG; Rajala-Schultz PJ; Daniels JB
    Vet Dermatol; 2015 Oct; 26(5):334-8, e70-1. PubMed ID: 26216025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study on the comparative minimum inhibitory and mutant prevention concentration values for moxifloxacin and pradofloxacin against canine and human isolates of Staphylococcus pseudintermedius and S. schleiferi.
    Plowgian C; Blondeau JM; Levinson M; Rosenkrantz W
    Vet Dermatol; 2019 Dec; 30(6):481-e142. PubMed ID: 31486554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility monitoring of canine and feline skin and ear pathogens isolated from European veterinary clinics: results of the ComPath Surveillance programme.
    de Jong A; Youala M; El Garch F; Simjee S; Rose M; Morrissey I; Moyaert H
    Vet Dermatol; 2020 Dec; 31(6):431-e114. PubMed ID: 32924232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria.
    Asín E; Isla A; Canut A; Rodríguez Gascón A
    Int J Antimicrob Agents; 2012 Oct; 40(4):313-22. PubMed ID: 22921422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the pharmacokinetic-pharmacodynamic cut-off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing.
    Bousquet-Mélou A; Schneider M; El Garch F; Broussou DC; Ferran AA; Lallemand EA; Triboulloy C; Damborg P; Toutain PL
    Equine Vet J; 2021 Sep; 53(5):1047-1055. PubMed ID: 33169427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of canine methicillin-resistant Staphylococcus pseudintermedius strains to pradofloxacin.
    Kizerwetter-Świda M; Chrobak-Chmiel D; Rzewuska M; Binek M
    J Vet Diagn Invest; 2016 Sep; 28(5):514-8. PubMed ID: 27449131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
    Heinen E
    J Vet Pharmacol Ther; 2002 Feb; 25(1):1-5. PubMed ID: 11874520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Van PH; Thinh LQ; Koo SH; Tan SH; Lim PQ; Sivhour C; Lamleav L; Somary N; Sosorphea S; Lagamayo E; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i19-i42. PubMed ID: 32337597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.
    Van PH; Binh PT; Minh NH; Morrissey I; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i93-102. PubMed ID: 27048586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs.
    Park Y; Oh J; Park S; Sum S; Song W; Chae J; Park H
    BMC Vet Res; 2020 Apr; 16(1):111. PubMed ID: 32293442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a fluorescence resonance energy transfer quantitative polymerase chain reaction assay for identification of gyrA mutations conferring enrofloxacin resistance in canine urinary Escherichia coli isolates and canine urine specimens.
    Behringer MG; Boothe DM; Thungrat K
    Am J Vet Res; 2018 Jul; 79(7):755-761. PubMed ID: 29943633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.